368 related articles for article (PubMed ID: 22935534)
1. Role of phospholipid oxidation products in atherosclerosis.
Lee S; Birukov KG; Romanoski CE; Springstead JR; Lusis AJ; Berliner JA
Circ Res; 2012 Aug; 111(6):778-99. PubMed ID: 22935534
[TBL] [Abstract][Full Text] [Related]
2. Metalloproteinase processing of HBEGF is a proximal event in the response of human aortic endothelial cells to oxidized phospholipids.
Lee S; Springstead JR; Parks BW; Romanoski CE; Palvolgyi R; Ho T; Nguyen P; Lusis AJ; Berliner JA
Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1246-54. PubMed ID: 22402363
[TBL] [Abstract][Full Text] [Related]
3. Postprandial lipoproteins and the molecular regulation of vascular homeostasis.
Botham KM; Wheeler-Jones CP
Prog Lipid Res; 2013 Oct; 52(4):446-64. PubMed ID: 23774609
[TBL] [Abstract][Full Text] [Related]
4. Protein targets of oxidized phospholipids in endothelial cells.
Gugiu BG; Mouillesseaux K; Duong V; Herzog T; Hekimian A; Koroniak L; Vondriska TM; Watson AD
J Lipid Res; 2008 Mar; 49(3):510-20. PubMed ID: 18071189
[TBL] [Abstract][Full Text] [Related]
5. High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory.
Gharavi NM; Gargalovic PS; Chang I; Araujo JA; Clark MJ; Szeto WL; Watson AD; Lusis AJ; Berliner JA
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1346-53. PubMed ID: 17379837
[TBL] [Abstract][Full Text] [Related]
6. Characterization of oxidized phospholipids in oxidatively modified low density lipoproteins by nanoflow liquid chromatography-tandem mass spectrometry.
Lee JY; Lim S; Park S; Moon MH
J Chromatogr A; 2013 May; 1288():54-62. PubMed ID: 23523068
[TBL] [Abstract][Full Text] [Related]
7. CD36 in Atherosclerosis: Pathophysiological Mechanisms and Therapeutic Implications.
Tian K; Xu Y; Sahebkar A; Xu S
Curr Atheroscler Rep; 2020 Aug; 22(10):59. PubMed ID: 32772254
[TBL] [Abstract][Full Text] [Related]
8. [Oxidized phospholipids and atherosclerosis].
Zhao M; Liu BY; Qin SC
Sheng Li Xue Bao; 2021 Feb; 73(1):69-81. PubMed ID: 33665662
[TBL] [Abstract][Full Text] [Related]
9. Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo.
Gharavi NM; Alva JA; Mouillesseaux KP; Lai C; Yeh M; Yeung W; Johnson J; Szeto WL; Hong L; Fishbein M; Wei L; Pfeffer LM; Berliner JA
J Biol Chem; 2007 Oct; 282(43):31460-8. PubMed ID: 17726017
[TBL] [Abstract][Full Text] [Related]
10. Sphingolipids in atherosclerosis and vascular biology.
Chatterjee S
Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1523-33. PubMed ID: 9763522
[TBL] [Abstract][Full Text] [Related]
11. Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells.
Raman P; Khanal S
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34064112
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 receptor agonist dulaglutide prevents ox-LDL-induced adhesion of monocytes to human endothelial cells: An implication in the treatment of atherosclerosis.
Chang W; Zhu F; Zheng H; Zhou Z; Miao P; Zhao L; Mao Z
Mol Immunol; 2019 Dec; 116():73-79. PubMed ID: 31630078
[TBL] [Abstract][Full Text] [Related]
13. Role of Ox-LDL and LOX-1 in Atherogenesis.
Kattoor AJ; Kanuri SH; Mehta JL
Curr Med Chem; 2019; 26(9):1693-1700. PubMed ID: 29737246
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis?
Wei Y; Nazari-Jahantigh M; Neth P; Weber C; Schober A
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):449-54. PubMed ID: 23324496
[TBL] [Abstract][Full Text] [Related]
15. Oxidized phospholipid content destabilizes the structure of reconstituted high density lipoprotein particles and changes their function.
Kar S; Patel MA; Tripathy RK; Bajaj P; Suvarnakar UV; Pande AH
Biochim Biophys Acta; 2012 Sep; 1821(9):1200-10. PubMed ID: 22634518
[TBL] [Abstract][Full Text] [Related]
16. Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells.
Vendrov AE; Hakim ZS; Madamanchi NR; Rojas M; Madamanchi C; Runge MS
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2714-21. PubMed ID: 17823367
[TBL] [Abstract][Full Text] [Related]
17. Phospholipid hydrolysis of mildly oxidized LDL reduces their cytotoxicity to cultured endothelial cells. Potential protective role against atherogenesis.
Schmitt A; Nègre-Salvayre A; Troly M; Valdiguié P; Salvayre R
Biochim Biophys Acta; 1995 Jun; 1256(3):284-92. PubMed ID: 7786889
[TBL] [Abstract][Full Text] [Related]
18. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.
Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
Cardiovasc Pathol; 2018; 33():6-15. PubMed ID: 29268138
[TBL] [Abstract][Full Text] [Related]
19. Oxidized phospholipid species promote in vivo differential cx43 phosphorylation and vascular smooth muscle cell proliferation.
Johnstone SR; Ross J; Rizzo MJ; Straub AC; Lampe PD; Leitinger N; Isakson BE
Am J Pathol; 2009 Aug; 175(2):916-24. PubMed ID: 19608875
[TBL] [Abstract][Full Text] [Related]
20. Oxidized phospholipids in Doxorubicin-induced cardiotoxicity.
Koleini N; Nickel BE; Edel AL; Fandrich RR; Ravandi A; Kardami E
Chem Biol Interact; 2019 Apr; 303():35-39. PubMed ID: 30707978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
